Evestra Prodrug 6 Month Injectable
Description: Evestra is advancing research on a technology that could lead to long-acting injectable fertility control for women by applying its proprietary prodrug platform technology to the development of the product.
Product Details
User: Female
Hormonal: Yes
Delivery Method: Injectable
Duration Type: Short-acting
Duration: 6 months
Regimen: - one injection every 6 months
- one injection every 6 months
Multipurpose Preventive Technology (MPT): No
Status Details
Developer: Evestra, Inc.
Project Phase: Discovery and Early Development
Development Stage: Prototype Development
Active Development: Yes
Status Details: - Received a grant in 2016 from the Bill & Melinda Gates Foundation.
- Received a grant in 2016 from the Bill & Melinda Gates Foundation.
Additional Information
References: Evestra, Inc. website: http://evestra.com.previewc45.carrierzone.com//index.html
Evestra, Inc. website: http://evestra.com.previewc45.carrierzone.com//index.html